Sartorius Stedim Biotech | Income Statement
Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
588
684
884
1,052
1,081
1,212
Cost of Goods Sold (COGS) incl. D&A
295
346
433
525
526
583
Gross Income
293
337
452
527
555
630
SG&A Expense
194
217
259
290
310
344
EBIT
99
-
197
243
243
283
Unusual Expense
1
9
7
18
23
26
Non Operating Income/Expense
1
2
4
2
9
41
Interest Expense
4
12
16
13
8
15
Pretax Income
94
105
170
213
221
285
Income Tax
27
31
50
57
57
75
Consolidated Net Income
67
74
119
156
164
210
Net Income
66
72
118
154
161
208
Net Income After Extraordinaries
66
72
118
154
161
208
Net Income Available to Common
66
72
118
154
161
208
EPS (Basic)
0.72
0.79
1.28
1.67
1.75
2.26
Basic Shares Outstanding
92
92
92
92
92
92
EPS (Diluted)
0.72
0.79
1.28
1.67
1.75
2.26
Diluted Shares Outstanding
92
92
92
92
92
92
EBITDA
129
159
237
287
294
344
Other Operating Expense
-
4
4
6
1
2
Non-Operating Interest Income
-
-
-
-
-
-
Minority Interest Expense
1
1
1
2
3
2
About Sartorius Stedim Biotech
View Profile
